These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15985649)

  • 1. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Beatrice S; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    Am J Public Health; 2005 Aug; 95(8):1439-44. PubMed ID: 15985649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
    Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug injection rates and needle-exchange use in New York City, 1991-1996.
    Marmor M; Shore RE; Titus S; Chen X; Des Jarlais DC
    J Urban Health; 2000 Sep; 77(3):359-68. PubMed ID: 10976610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.
    Rothman J; Rudnick D; Slifer M; Agins B; Heiner K; Birkhead G
    J Urban Health; 2007 Mar; 84(2):226-42. PubMed ID: 17216572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
    Des Jarlais DC; Arasteh K; Friedman SR
    Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.
    Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C
    AIDS Behav; 2013 Sep; 17(7):2501-9. PubMed ID: 23640654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.
    Des Jarlais DC; Kling R; Hammett TM; Ngu D; Liu W; Chen Y; Binh KT; Friedmann P
    AIDS; 2007 Dec; 21 Suppl 8():S109-14. PubMed ID: 18172378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
    Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
    Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in HIV risk behavior of injection drug users in New York City by health care setting.
    Turner AK; Harripersaud K; Crawford ND; Rivera AV; Fuller CM
    AIDS Care; 2013; 25(10):1321-9. PubMed ID: 23451991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic proximity, policy and utilization of syringe exchange programmes.
    Rockwell R; Des Jarlais DC; Friedman SR; Perlis TE; Paone D
    AIDS Care; 1999 Aug; 11(4):437-42. PubMed ID: 10533536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.
    Wiessing L; Likatavicius G; Klempová D; Hedrich D; Nardone A; Griffiths P
    Am J Public Health; 2009 Jun; 99(6):1049-52. PubMed ID: 19372511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts.
    Heimer R; Grau LE; Curtin E; Khoshnood K; Singer M
    Am J Public Health; 2007 Jan; 97(1):110-6. PubMed ID: 17138916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.